What is NovoTTF?
What is it? The NovoTTF-100L System is the first device indicated to be used in conjunction with a standard two-drug chemotherapy to treat patients with a cancerous tumor, malignant pleural mesothelioma (MPM) that is unable to be removed via surgery (unresectable).
Is optune FDA approved?
Optune has been FDA approved for the treatment of recurrent GBM and has received CE mark for the treatment of both recurrent and newly diagnosed GBM. The device has been available commercially in the European Union (EU) 42009 and in the US since October 2011.
Is Novocure FDA approved?
Novocure (NASDAQ: NVCR) today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) supplement, reducing the enrollment requirement for its LUNAR trial to 276 patients with 12 months follow-up.
What does the company Novocure do?
of Novocure. We are a global oncology company striving to extend survival in some of the most aggressive forms of cancer.
What is optune device?
Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.
What is Novo TTF?
NovoTTF-100L is a non-invasive, antimitotic cancer treatment that delivers Tumor Treating Fields to the region of the tumor. Tumor Treating Fields therapy uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.
Is glioblastoma always fatal?
Glioblastoma incidence is very low among all cancer types, i.e., 1 per 10 000 cases. However, with an incidence of 16% of all primary brain tumors it is the most common brain malignancy and is almost always lethal [5,6].
Where is novocure located?
Saint Helier, Jersey
Novocure is a commercial-stage oncology company based in Saint Helier, Jersey. It develops treatments for solid-tumor cancers.
Who makes novocure?
In 2000, Yoram Palti, our founder and professor emeritus of physiology and biophysics at the Technion — Israel Institute of Technology, sought to leverage his expertise in biophysics to develop a new way to treat solid tumor cancers that would destroy tumor cells while sparing healthy tissue and avoiding many of the ….
Is NovoCure a biotech company?
Novocure is one of the only companies in the biotechnology industry that lives up to its technology’s hype. Within a growing technological world and growing space for possible cancer treatments, Novcure will continue to gain recognition through its Tumor Treating Fields.
Is NovoCure a good company?
Amazing Company to Work for Novocure has a clearly stated and established set of mission, vision, and values, that become an amazing company culture. It is extremely rewarding to work for a company that is so driven by our patient-forward vision. Really amazing benefits, paid time off, vacation time, etc.
Are there any side effects to the novottf system?
Only skin redness and open sores are related to the NovoTTF-100A System treatment itself. By using the NovoTTF-100A System instead of cancer drugs, patients would avoid many of the side effects due to cancer drugs. These include infections, nausea, vomiting, loss of appetite, and tiredness.
What kind of cancer treatment does Novocure use?
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, Tumor Treating Fields. Tumor Treating Fields is a cancer therapy that uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.
How does the novottf 100A tumor treatment system work?
The NovoTTF-100A System is a portable device. It produces electric fields, called tumor treatment fields (“TTFields”). Transducer arrays connected to the device deliver TTFields to your head. The TTFields are intended to destroy brain cancer cells. The device and battery are carried in a shoulder bag. You should use them all the time.
How long can you use novottf at home?
Patients use the device at home for at least 18 hours a day (with minimal breaks) until disease progression or in the absence of significant toxicity. The device is plugged into a power supply or uses the rechargeable battery when a patient wants to move around while wearing the device.